Evidence map›Paper›PMID 34335023›Full record

ArticleInternational journal of chronic obstructive pulmonary disease2021

Narrative Analysis of the Impact of COVID-19 on Patients with Chronic Obstructive Pulmonary Disease, Their Caregivers, and Healthcare Professionals in Italy.

Eleonora Volpato, Stefano Centanni, Paolo Banfi, Salvatore D'Antonio, Enrico Peterle, Filomena Bugliaro, Ignazio Grattagliano, Alessio Piraino, Luca Cavalieri, Alfio Pennisi and 3 more

Open access · goldAbstract read
In one paragraph

Article in International journal of chronic obstructive pulmonary disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. The Psychosocial Impact of the COVID-19 Pandemic on Chronic Care Patients.Journal of the American Medical Directors Association · 2023
    Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 1 country.

Eleonora VolpatoHealthcare Area, ISTUD Foundation, Milan, Italy.ORCID 0000-0003-0266-6386
Stefano CentanniDepartment of Health Sciences Università degli Studi di Milano - Respiratory UnitASST Santi Paolo e Carlo, Milan, Italy.
Paolo BanfiHeart-Respiratory Rehabilitation Unit, IRCCS Fondazione Don Carlo Gnocchi, Milan, Italy.ORCID 0000-0001-8162-0751
Salvatore D'AntonioAssociazione ONLUS BPCO, Rome, Italy.
Enrico PeterleGeneral Practitioner, Local Health Department 3 Serenissima, Venezia, Italy.
Filomena BugliaroFederasma e Allergie-Federazione Italiana Pazienti OdV, Prato, Italy.
Ignazio GrattaglianoItalian College of General Practitioners, Bari, Italy.
Alessio PirainoChiesi Farmaceutici S.p.A, Parma, italy.ORCID 0000-0002-8029-2159
Luca CavalieriChiesi Farmaceutici S.p.A, Parma, italy.
Alfio PennisiRehabilitation Clinic Monsignor Calaciura Biancavilla, Catania, Italy.
Gianluca DanesiLocal Health Department Romagna Pulmonology Ravenna, Ravenna, Italy.
Luigi SantoiemmaGeneral Practitioner, Local Health Department Bari, Bari, Italy.
Maria Giulia MariniHealthcare Area, ISTUD Foundation, Milan, Italy.
Chiesi (Italy) · ITAssociazione Italiana Vulvodinia Onlus · ITAzienda Unità Sanitaria Locale Della Romagna · ITDon Carlo Gnocchi Foundation · ITSocietà Italiana di Medicina Generale · ITUniversità Cattolica del Sacro Cuore · ITUniversity of Bari Aldo Moro · ITUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: The COVID-19 pandemic has disrupted many lives, including those of people suffering from chronic obstructive pulmonary disease (COPD) and their caregivers. The main aim of this study was to use narrative medicine, a validated approach promoting quality of care to explore how the COVID-19 pandemic impacted the quality of care, quality of life, psychological factors and social factors of people affected by COPD and their caregivers and healthcare professionals (HCPs). A secondary aim was to explore the role of telemedicine in combating isolation and providing access to care. Methods: A cross-sectional observational narrative medicine study was conducted between July and November 2020 across Italy. An online semi-structured questionnaire with a narrative plot was completed by 146 participants (79 COPD patients, 24 caregivers, and 43 HCPs). Narrations were analyzed with descriptive statistics and evaluated using NVivo 11 software to break down the text and identify recurring themes and major semantic clusters. Results: During the first lockdown, 58.22% of responses from COPD patients indicated terror, fear and/or apprehension; at reopening, this figure was 35.44%. Among caregivers, these figures were 100% at first lockdown and 45.83% at reopening. The metaphors most commonly used by patients to describe COPD and COVID-19 were monster and murderer, respectively. Patients described their homes more often as clean and lonely than as offering no shelter. The narratives of 42 COPD patients (45.2%) described coping. Only 12.6% of COPD patients reported regular access to medical visits during lockdown, while 59.1% of general practitioners and pulmonologists reported using telemedicine, which was perceived as satisfactory by both patients and caregivers. Conclusion: It is relevant to aim for a multidisciplinary and multilevel system of care that empowers telemedicine and integrates specific psychological support programs for COPD patients and their caregivers.

Indexed as

COVID-19Pulmonary Disease, Chronic ObstructiveTelemedicineCaregiversCommunicable Disease ControlCross-Sectional StudiesHumansItalyPandemicsQuality of LifeSARS-CoV-2chronic obstructive pulmonary diseaseCOPDCOVID-19narrative medicinequality of life

Identifiers

PMID34335023
PMCPMC8318732
OpenAlexW3186844193

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.